The medical information is growing exponentially. Thanks to the years of innovations in healthcare, drug development, clinical trials, pharmacovigilance, approval processes, EHRs, lab reports, scientific publications, and the list goes on. Despite the growing knowledge, biopharma companies have witnessed declining success rates and stagnant pipelines in drug discovery and development.

Artificial intelligence is all geared up to drive improvements and efficiencies in the pharma and healthcare sector like any other field where it has successfully left a mark. Irrespective of the field, reducing turnaround time and enhancing customer delight and outcomes is the ultimate goal. Driven by machine learning, artificial intelligence, natural language processing, text-analytics and virtual assistance, cognitive technology does the same for biopharma companies. Download this e-book to learn how.

Key Takeaways

icon

Barriers to Drug Development Process

How big data volumes are hindering the progress of biopharma companies by increasing timelines & costs

icon

Cognitive Technology to Redefine Pharma Sector

How cognitive technology accelerates R&D, optimizes clinical trials & shortens drug time to market

icon

Factors Driving Cognitive Technology Adoption

Key considerations for adopting the best AI-driven enterprise search for your pharma business